Antibiotics for exacerbations of chronic bronchitis. 1987

F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
July 1987, Lancet (London, England),
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
December 1993, Seminars in respiratory infections,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
April 2010, Expert review of anti-infective therapy,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
September 1988, The Western journal of medicine,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
July 2002, Expert opinion on investigational drugs,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
March 2017, Expert opinion on investigational drugs,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
June 1997, Chest,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
January 1986, Ugeskrift for laeger,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
December 1969, British medical journal,
F Manresa, and R Blavia, and R Martin, and J Liñares, and B Rodriguez, and R Verdaguer
October 1997, Hospital practice (1995),
Copied contents to your clipboard!